Company intelligence / Profile preview

Buckley

Mississauga, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Buckley's is a long-standing Canadian over-the-counter respiratory health medicines brand focused on cough, cold, and flu symptom relief. Its portfolio includes syrups, pills, liquid gels, and lozenges marketed for symptoms such as cough, sore throat pain, nasal congestion, chest congestion, and related cold/flu complaints. Historically associated with W.K. Buckley Limited, the brand is now part of the Haleon group of companies in Canada. Buckley's is not a biotech or clinical-stage therapeutics developer; it is a commercial consumer healthcare brand with established marketed products.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Buckley.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Buckley.

Explore the full profile